北京德恒（无锡）律师事务所 关于无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 的法律意见 无锡市滨湖区太湖新城金融一街 15 号平安财富中心 8 层 电话:0510-85215998 传真:0510-85215778 邮编:214000 北京德恒（无锡）律师事务所 关于无锡阿科力科技股份有限公司 2024 年第二次临时股东大会的法律意见 北京德恒（无锡）律师事务所 关于无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 本所律师依据《证券法》《律师事务所从事证券法律业务管理办法》《律师 事务所证券法律业务执业规则（试行）》等规定以及本法律意见出具日以前已经 发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽责和诚实信用原则， 进行了充分的核查验证，保证本法律意见所认定的事实真实、准确、完整，所发 1 北京德恒（无锡）律师事务所 关于无锡阿科力科技股份有限公司 2024 年第二次临时股东大会的法律意见 表的结论性意见合法、准确，不存在虚假记载、误导性陈述或者重大遗漏，并承 担相应法律责任。 的法律意见 致：无锡阿科力科技股份有限公司 北京德恒（无锡）律师事务所受无锡阿科力科技股份有限公司 ...

证券代码：603722 证券简称：阿科力 公告编号：2024-063 无锡阿科力科技股份有限公司 2024 年第二次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 1、出席会议的股东和代理人人数 | 97 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 35,227,871 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 36.8106 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，公司董事长朱学军先生担任本次股东大会 的主持人，会议采用现场投票和网络投票相结合的表决方式。本次会议的召开、 本次会议是否有否决议案：无 一、 会议召开和出席情况 召集及表决方式符合《公司法》及《公司章程》的规定。 二、 议案审议情况 (一) 非累积投票议案 1、 议案名称：关于变更公司注册资本、经营范围、修订《公司章程》及办理工 商变更登记的议案 审议结果 ...

证券代码：603722 证券简称：阿科力 公告编号：2024-062 重要内容提示： 会议召开时间：2024 年 11 月 15 日(星期五) 下午 13:00-14:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 11 月 08 日(星期五) 至 11 月 14 日(星期四)16:00 前登录上 证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zq@chinaacryl.com 进行提问。说明会上将对投资者普遍关注的问题进行回答。 无锡阿科力科技股份有限公司 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 无锡阿科力科技股份有限公司（以下简称"公司"）已于 2024 年 10 月 31 日发布公司 2024 年第三季度报告，为便于广大投资者更全面深入地了解公司 2024 年第三季度经营成果、财务状况，公司计划于 2024 年 11 月 15 ...

无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 会议材料 无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 会议材料 二零二四年十一月 无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 会议材料 无锡阿科力科技股份有限公司 2024 年第二次临时股东大会会议须知 根据中国证券监督管理委员会《上市公司股东大会规则》和《公司章程》 的有关规定，为确保无锡阿科力科技股份有限公司（以下简称"公司"）股东 大会顺利召开，特制定大会须知如下，望出席股东大会的全体人员遵守执行： 一、股东参加股东大会，应当认真履行其法定义务，不得侵犯其他股东权 益； 二、股东大会期间，全体出席人员应以维护股东的合法利益、以确保大会 正常秩序和议事效率为原则，认真履行法定职责； 三、出席大会的股东依法享有发言权、咨询权、表决权等各项权利，但需 由公司统一安排发言和解答； 四、任何人不得扰乱大会的正常秩序和会议程序；会议期间请关闭手机或 将其调至振动状态。 六、参加会议对象： 无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 会议材料 无锡阿科力科技股份有限公司 2024 年第二次临时股东大会 议 程 ...

Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company focuses on the research and production of new materials, primarily polyether amines and optical-grade polymer materials, with applications in wind turbine blades, shale gas extraction, automotive coatings, and optical lenses. It is a leading domestic producer of polyether amines and is actively developing cyclic olefin copolymers (COC/COP) to fill a market gap in high-transparency materials [4][5] - COC is a high-transparency material with superior optical properties and high technical barriers in its production. Currently, domestic production is non-existent, relying entirely on imports. The company is positioned to become the first domestic listed company to mass-produce COC/COP, with competitive pricing expected to be around 80,000 yuan per ton, compared to 120,000-160,000 yuan per ton from Japanese manufacturers [5][6] - The company is currently conducting downstream testing for its COC products, with plans for mass production in 2024. The projected net profits for 2024-2026 are estimated at -2 million yuan, 114 million yuan, and 424 million yuan, respectively, with corresponding PE ratios of 35.1X and 9.5X for 2025-2026 [6] Financial Summary - For the first nine months of 2024, the company reported revenues of 365 million yuan, a year-on-year decrease of 11.85%, and a net profit attributable to shareholders of -6.785 million yuan, a decline of 131.69%. The net cash flow from operating activities was 39.241 million yuan, down 28.31% [4][6] - The third quarter of 2024 saw revenues of 122 million yuan, down 8.84% year-on-year and 11.95% quarter-on-quarter, with a net profit of -8.768 million yuan, a year-on-year decrease of 267.72% and a quarter-on-quarter decline of 1207.17% [4][6] - The company's projected total revenue for 2024 is 438 million yuan, with expectations to grow to 1.146 billion yuan in 2025 and 3.175 billion yuan in 2026 [11]

Investment Rating - Buy (maintained) [1] Core Views - The company's COC (Cyclic Olefin Copolymer) has officially entered trial production, marking a critical step in its industrialization process [5] - Despite short-term operational pressures, the long-term prospects for COC industrialization are promising, supporting the "Buy" rating [3] - The company received a government subsidy of 110 million yuan to accelerate the industrialization of high-end materials [5] Financial Performance - Revenue for the first three quarters of 2024 was 365 million yuan, down 11.85% year-on-year [3] - Net profit attributable to shareholders was -6.785 million yuan, turning from profit to loss compared to the same period last year [3] - Gross margin declined due to intensified competition and lower product prices, particularly in the polyetheramine segment [3] - Expected net profit for 2024-2026 is 6 million, 96 million, and 183 million yuan, respectively, with EPS of 0.06, 1.01, and 1.92 yuan per share [3] Product Performance - Sales of fatty amines and optical materials (automotive coatings) were 14,410 tons and 4,990 tons, respectively, with year-on-year changes of -8.6% and +29.8% [4] - Average prices for fatty amines and optical materials were 14,842 yuan/ton and 30,071 yuan/ton (excluding tax), down 14.3% and 17.3% year-on-year [4] - The company's polyetheramine prices remain higher than the market average due to strong R&D capabilities and product structure adjustments [4] COC Industrialization Progress - The COC trial production plan was approved on September 21, 2024, and has officially entered the trial production phase [5] - The company's subsidiary received approval for "COC bottles for injectable drugs," marking progress in the pharmaceutical packaging sector [5] Financial Forecasts - Revenue for 2024-2026 is projected to be 509 million, 846 million, and 1.216 billion yuan, with year-on-year growth rates of -5.2%, 66.2%, and 43.7% [6] - Gross margins for 2024-2026 are expected to be 10.0%, 21.9%, and 25.9%, respectively [6] - ROE for 2024-2026 is forecasted at 0.8%, 11.7%, and 18.8% [6]

本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法 律责任。 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 法律责任。 一、会议召开情况 无锡阿科力科技股份有限公司（以下称"股份公司"）第四届董事会第十五次 会议于 2024 年 10 月 30 日在公司办公楼二层会议室召开，会议的通知于 2024 年 10 月 23 日以电话、短信通知的方式发出。股份公司董事共计 8 人，出席本次 董事会的董事共 8 人，出席会议人数符合《中华人民共和国公司法》和《无锡阿 科力科技股份有限公司章程》的规定。 二、 会议表决情况 经过参会董事充分讨论与审议，表决涉及关联董事回避的，除关联董事回避 表决外，非关联董事表决结果为一致通过。 具体表决情况如下： 1. 审议《关于公司 2024 年第三季度报告的议案》； 证券代码：603722 证券简称：阿科力 公告编号：2024-057 无锡阿科力科技股份有限公司 第四届董事会第十五次会议决议公 ...

证券代码：603722 证券简称：阿科力 公告编号：2024-061 无锡阿科力科技股份有限公司 关于设立全资香港子公司的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带 法律责任。 一、 对外投资概述 1、为了进一步拓展公司业务，满足市场及客户需求，提高市场反应速度， 根据经营发展及战略规划需要，无锡阿科力科技股份有限公司（以下简称"公司"） 拟使用自有资金出资 4,000 万元人民币或等值外币，在香港投资设立全资子公 司——阿科力（香港）有限公司（暂定名，最终名称以登记注册结果为准，以下 简称"香港子公司"）。 2、上述对外投资事项已经于 2024 年 10 月 30 日召开的第四届董事会第十五 次会议审议通过。公司董事会授权董事长朱学军先生全权代表公司签署、执行与 本次对外投资相关的法律性文件，并办理或在公司董事会授权范围内转授权公司 管理层办理相关事宜。 3、根据《上海证券交易所股票上市规则》、《对外投资管理制度》和《公司 章程》等相关规定，本次对外投资在公司董事会审议权限内，无需提交股东大会 审议。本 ...

Financial Performance - The company's operating revenue for Q3 2024 was ¥122,394,338.71, representing a decrease of 8.84% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was a loss of ¥8,767,930.79, with a year-to-date loss of ¥6,784,991.59[2]. - The company's operating revenue for the year-to-date period decreased by 11.85% compared to the same period last year, attributed to intensified industry competition leading to significant price declines[7]. - Total operating revenue for the first three quarters of 2024 was CNY 364,520,175.93, a decrease of 11.87% compared to CNY 413,523,872.47 in the same period of 2023[15]. - Net profit for the first three quarters of 2024 was CNY -7,089,185.82, compared to a net profit of CNY 20,789,037.10 in the same period of 2023, indicating a significant decline[16]. - Basic earnings per share for Q3 2024 was -¥0.10, reflecting a decrease due to reduced net profit[6]. - Basic earnings per share for Q3 2024 was CNY -0.08, compared to CNY 0.24 in Q3 2023, indicating a negative shift in profitability[17]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period decreased by 28.31% to ¥39,241,021.00[7]. - The company's cash flow from operating activities showed a significant decline, contributing to the overall decrease in net profit[16]. - In the first three quarters of 2024, the cash inflow from operating activities was CNY 369,538,205.40, a decrease of 14.7% compared to CNY 433,083,841.86 in the same period of 2023[18]. - The net cash flow from operating activities for the first three quarters of 2024 was CNY 39,241,021.00, down 28.3% from CNY 54,734,441.23 in 2023[19]. - The cash and cash equivalents at the end of Q3 2024 amounted to CNY 286,719,956.20, down from CNY 373,733,961.92 at the end of Q3 2023[20]. - The company experienced a net decrease in cash and cash equivalents of CNY 68,611,991.17 in Q3 2024, compared to an increase of CNY 127,676,606.21 in Q3 2023[20]. Assets and Liabilities - Total assets at the end of Q3 2024 were ¥976,469,686.84, an increase of 4.71% from the end of the previous year[3]. - The company's total liabilities increased to CNY 237,874,661.76 in Q3 2024 from CNY 169,247,670.02 in Q3 2023, representing an increase of 40.5%[14]. - Shareholders' equity attributable to the company decreased by 3.20% to ¥736,897,081.23 compared to the end of the previous year[3]. - The total equity attributable to shareholders decreased to CNY 736,897,081.23 in Q3 2024 from CNY 761,269,572.82 in Q3 2023, a decline of 3.2%[14]. - The company has a short-term loan liability of ¥197,040,500.00 as of September 30, 2024[12]. Operational Efficiency - The decline in gross profit margin was a significant factor contributing to the decrease in net profit for the current period[6]. - Total operating costs for the first three quarters of 2024 were CNY 368,365,927.17, down from CNY 392,129,155.72 in 2023, reflecting a reduction of 6.06%[15]. - The company reported a decrease in sales expenses to CNY 2,840,155.11 in Q3 2024 from CNY 5,262,832.72 in Q3 2023, a reduction of 46.0%[15]. - Research and development expenses for the first three quarters of 2024 were CNY 10,900,813.17, down from CNY 12,945,426.49 in the same period of 2023, a decrease of 15.8%[15]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 7,089[8]. - The largest shareholder, Zhu Xuejun, holds 21,912,700 shares, accounting for 24.92% of total shares[8]. Government Support and Other Income - The company recognized government subsidies amounting to ¥460,025.00 during the current period[4]. - The total non-recurring gains and losses for the year-to-date period amounted to ¥392,564.75[5]. - The company received CNY 24,115,210.64 in tax refunds during the first three quarters of 2024, an increase of 51.9% from CNY 15,882,657.12 in 2023[18]. Inventory and Receivables - Accounts receivable increased to ¥77,506,048.17 from ¥57,966,208.01 year-over-year[10]. - Inventory decreased to ¥39,129,575.65 from ¥45,851,839.48 year-over-year[12]. - Non-current assets increased to ¥517,959,116.58 from ¥409,929,635.90 year-over-year[12].

证券代码：603722 证券简称：阿科力 公告编号：2024-060 无锡阿科力科技股份有限公司 2024 年第三季度主要经营数据公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 无锡阿科力科技股份有限公司（以下简称"公司"）根据《上海证券交易所 上市公司自律监管指引第 3 号——行业信息披露》之《第十三号——化工》和《关 于做好主板上市公司 2024 年第三季度报告披露工作的重要提醒》要求，现将 2024 年第三季度主要经营数据披露如下： | 主要产品 | 2024 | 年 1-9 | 月产量 | 2024 年 | 1-9 | 月销量 | 2024 年 | 1-9 | 月销售 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | （吨） | | （吨） | | | 收入（万元） | | | | 脂肪胺 | | 13,882.20 | | 14,410.18 | | | 21,388.20 | | | | 光学材料 ...